Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:21415578rdf:typepubmed:Citationlld:pubmed
pubmed-article:21415578lifeskim:mentionsumls-concept:C0013216lld:lifeskim
pubmed-article:21415578lifeskim:mentionsumls-concept:C2239176lld:lifeskim
pubmed-article:21415578lifeskim:mentionsumls-concept:C0013089lld:lifeskim
pubmed-article:21415578lifeskim:mentionsumls-concept:C1579762lld:lifeskim
pubmed-article:21415578lifeskim:mentionsumls-concept:C0009491lld:lifeskim
pubmed-article:21415578lifeskim:mentionsumls-concept:C0796679lld:lifeskim
pubmed-article:21415578lifeskim:mentionsumls-concept:C1134564lld:lifeskim
pubmed-article:21415578lifeskim:mentionsumls-concept:C0205269lld:lifeskim
pubmed-article:21415578lifeskim:mentionsumls-concept:C0205179lld:lifeskim
pubmed-article:21415578pubmed:issue4lld:pubmed
pubmed-article:21415578pubmed:dateCreated2011-3-18lld:pubmed
pubmed-article:21415578pubmed:abstractTextTransarterial chemoembolization (TACE) has long been used as a palliative therapy for unresectable hepatocellular carcinoma (HCC). High-dose hepatic arterial infusion chemotherapy (HAIC) has showed favorable outcomes in patients with intractable, advanced HCC. The aim of this study was to compare the effectiveness and safety of high-dose HAIC and conventional TACE using doxorubicin for advanced HCC.lld:pubmed
pubmed-article:21415578pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21415578pubmed:languageenglld:pubmed
pubmed-article:21415578pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21415578pubmed:citationSubsetIMlld:pubmed
pubmed-article:21415578pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21415578pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21415578pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21415578pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21415578pubmed:statusMEDLINElld:pubmed
pubmed-article:21415578pubmed:monthDeclld:pubmed
pubmed-article:21415578pubmed:issn1738-222Xlld:pubmed
pubmed-article:21415578pubmed:authorpubmed-author:UmSoon HoSHlld:pubmed
pubmed-article:21415578pubmed:authorpubmed-author:YoonSeung...lld:pubmed
pubmed-article:21415578pubmed:authorpubmed-author:ChoiJong...lld:pubmed
pubmed-article:21415578pubmed:authorpubmed-author:HanKwang...lld:pubmed
pubmed-article:21415578pubmed:authorpubmed-author:KimYoung...lld:pubmed
pubmed-article:21415578pubmed:authorpubmed-author:KimHee YeonHYlld:pubmed
pubmed-article:21415578pubmed:authorpubmed-author:BaeSi HyunSHlld:pubmed
pubmed-article:21415578pubmed:authorpubmed-author:HwangJae...lld:pubmed
pubmed-article:21415578pubmed:authorpubmed-author:YimHyung...lld:pubmed
pubmed-article:21415578pubmed:authorpubmed-author:ParkJun...lld:pubmed
pubmed-article:21415578pubmed:authorpubmed-author:JangByoung...lld:pubmed
pubmed-article:21415578pubmed:authorpubmed-author:KimSang...lld:pubmed
pubmed-article:21415578pubmed:authorpubmed-author:KimJin DongJDlld:pubmed
pubmed-article:21415578pubmed:authorpubmed-author:WooHyun...lld:pubmed
pubmed-article:21415578pubmed:authorpubmed-author:SeoYeon...lld:pubmed
pubmed-article:21415578pubmed:authorpubmed-author:Korean...lld:pubmed
pubmed-article:21415578pubmed:issnTypePrintlld:pubmed
pubmed-article:21415578pubmed:volume16lld:pubmed
pubmed-article:21415578pubmed:ownerNLMlld:pubmed
pubmed-article:21415578pubmed:authorsCompleteYlld:pubmed
pubmed-article:21415578pubmed:pagination355-61lld:pubmed
pubmed-article:21415578pubmed:meshHeadingpubmed-meshheading:21415578...lld:pubmed
pubmed-article:21415578pubmed:meshHeadingpubmed-meshheading:21415578...lld:pubmed
pubmed-article:21415578pubmed:meshHeadingpubmed-meshheading:21415578...lld:pubmed
pubmed-article:21415578pubmed:meshHeadingpubmed-meshheading:21415578...lld:pubmed
pubmed-article:21415578pubmed:meshHeadingpubmed-meshheading:21415578...lld:pubmed
pubmed-article:21415578pubmed:meshHeadingpubmed-meshheading:21415578...lld:pubmed
pubmed-article:21415578pubmed:meshHeadingpubmed-meshheading:21415578...lld:pubmed
pubmed-article:21415578pubmed:meshHeadingpubmed-meshheading:21415578...lld:pubmed
pubmed-article:21415578pubmed:meshHeadingpubmed-meshheading:21415578...lld:pubmed
pubmed-article:21415578pubmed:meshHeadingpubmed-meshheading:21415578...lld:pubmed
pubmed-article:21415578pubmed:meshHeadingpubmed-meshheading:21415578...lld:pubmed
pubmed-article:21415578pubmed:meshHeadingpubmed-meshheading:21415578...lld:pubmed
pubmed-article:21415578pubmed:meshHeadingpubmed-meshheading:21415578...lld:pubmed
pubmed-article:21415578pubmed:meshHeadingpubmed-meshheading:21415578...lld:pubmed
pubmed-article:21415578pubmed:meshHeadingpubmed-meshheading:21415578...lld:pubmed
pubmed-article:21415578pubmed:meshHeadingpubmed-meshheading:21415578...lld:pubmed
pubmed-article:21415578pubmed:year2010lld:pubmed
pubmed-article:21415578pubmed:articleTitleA comparative study of high-dose hepatic arterial infusion chemotherapy and transarterial chemoembolization using doxorubicin for intractable, advanced hepatocellular carcinoma.lld:pubmed
pubmed-article:21415578pubmed:affiliationDepartment of Internal Medicine, The Catholic University of Korea School of Medicine, Seoul, Korea.lld:pubmed
pubmed-article:21415578pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:21415578pubmed:publicationTypeClinical Triallld:pubmed
pubmed-article:21415578pubmed:publicationTypeComparative Studylld:pubmed
pubmed-article:21415578pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
pubmed-article:21415578pubmed:publicationTypeMulticenter Studylld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:21415578lld:pubmed